ULTRAFILTERABLE ALUMINUM IN HUMAN SERUM - AN IN-VITRO COMPARATIVE-STUDY BETWEEN DESFERRIOXAMINE AND A NEW CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE

被引：0
|
作者：
MARTIN, JLF [1 ]
PARAJON, JP [1 ]
FRAGA, PID [1 ]
ELORRIAGA, R [1 ]
CANNATA, JB [1 ]
机构：
[1] HOSP CENT ASTURIAS,BONE & MINERAL RES UNIT,OVIEDO,SPAIN
来源：
KIDNEY INTERNATIONAL | 1994年 / 46卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：587 / 587
页数：1
相关论文
共 44 条
  • [21] EFFECTS OF 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) ON CELL-PROLIFERATION
    ELORRIAGA, R
    FRAGA, PM
    NAVES, ML
    CANNATA, JB
    KIDNEY INTERNATIONAL, 1994, 46 (02) : 587 - 587
  • [22] 4-WEEK ORAL TOXICITY STUDY OF 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) IN UREMIC RATS
    GOMEZ, M
    DOMINGO, JL
    DELCASTILLO, D
    LLOBET, JM
    CORBELLA, J
    VETERINARY AND HUMAN TOXICOLOGY, 1995, 37 (04) : 346 - 348
  • [23] URINARY IRON EXCRETION DEPENDS ON THE MODE OF ADMINISTRATION OF THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE IN PATIENTS WITH HOMOZYGOUS BETA-THALASSEMIA
    FASSOS, FF
    KLEIN, J
    FERNANDES, D
    MATSUI, D
    OLIVIERI, NF
    KOREN, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (01) : 70 - 75
  • [24] Effective complex formation in the interaction of 1,2-dimethyl-3-hydroxypyrid-4-one (Deferiprone or L1) with uranium(VI)
    I. Pashalidis
    G. J. Kontoghiorghes
    Journal of Radioanalytical and Nuclear Chemistry, 1999, 242 : 181 - 184
  • [25] Effective complex formation in the interaction of 1,2-dimethyl-3-hydroxypyrid-4-one (Deferiprone or L1) with uranium(VI)
    Pashalidis, I
    Kontoghiorghes, GJ
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 1999, 242 (01) : 181 - 184
  • [26] ASSESSMENT OF ORAL 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) IN DIFFERENT FERRIKINETIC MODELS IN ANIMALS AND HUMANS
    RAHMAN, YE
    BRITISH JOURNAL OF HAEMATOLOGY, 1991, 77 (03) : 441 - 442
  • [27] ORAL IRON CHELATION WITH 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) IN IRON-LOADED THALASSEMIA PATIENTS
    OLIVIERI, NF
    MATSUI, D
    LIU, PP
    BLENDIS, L
    CAMERON, R
    MCCLELLAND, RA
    TEMPLETON, DM
    KOREN, G
    BONE MARROW TRANSPLANTATION, 1993, 12 : 9 - 11
  • [28] CORRELATION OF IRON EXCHANGE BETWEEN THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) AND TRANSFERRIN AND POSSIBLE ANTIANEMIC EFFECTS OF L1 IN RHEUMATOID-ARTHRITIS
    VREUGDENHIL, G
    SWAAK, AJG
    DEJEUJASPARS, C
    VANEIJK, HG
    ANNALS OF THE RHEUMATIC DISEASES, 1990, 49 (11) : 956 - 957
  • [29] COMPARATIVE IRON MOBILIZING ACTIONS OF DEFEROXAMINE, 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, AND PYRIDOXAL ISONICOTINOYL HYDRAZONE IN IRON HYDROXAMATE-LOADED MICE
    GALE, GR
    LITCHENBERG, WH
    SMITH, AB
    SINGH, PK
    CAMPBELL, RA
    JONES, MM
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1991, 73 (03): : 299 - 313
  • [30] DETAILED INVESTIGATION OF IMMUNE FUNCTION IN PATIENTS (PTS) RECEIVING THE IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) - NO EVIDENCE OF ABNORMALITY AFTER 3 YEARS OF THERAPY
    BERKOVITCH, M
    MEYDAN, N
    DONSKY, J
    COLLINS, AF
    SHER, GD
    MATSUI, D
    KOREN, G
    HACKMAN, R
    ROIFMAN, C
    OLIVIERI, NF
    BLOOD, 1993, 82 (10) : A360 - A360
12345